ROCHESTER, N.Y., Oct. 21 /PRNewswire-FirstCall/ —
VirtualScopics, Inc. (Nasdaq:
VSCP), a leading provider of quantitative imaging for clinical
trials, announced today that before the market opens on Thursday,
November 11, 2010 it will release its third quarter 2010 financial
results. The company will host a conference call that morning at
11:00 a.m. EST.
VirtualScopics’ President and Chief Executive Officer, Jeff
Markin, and Chief Business and Financial Officer, Molly Henderson,
will provide a business update and discuss the company’s results
for the quarter ended September 30, 2010 during the conference
call.
Interested participants should call 877-407-8035 when calling
within the United States or +1 201-689-8035 when calling
internationally. This call can also be accessed at www.virtualscopics.com
and will be available for 30 days after the call.
About VirtualScopics, Inc.VirtualScopics, Inc. is a leading
provider of imaging solutions to accelerate drug and medical device
development. VirtualScopics has developed a robust software
platform for analysis and modeling of both structural and
functional medical images. In combination with
VirtualScopics’ industry-leading experience and expertise in
advanced imaging biomarker measurement, this platform provides a
uniquely clear window into the biological activity of drugs and
devices in clinical trial patients, allowing sponsors to make
better decisions faster. For more information about
VirtualScopics, visit www.virtualscopics.com.
Forward-Looking Statements The statements contained in this
press release that are not purely historical are forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended and Section 21E of the Securities Exchange Act
of 1934, as am
‘/>”/>
